Clinical Trial Update: Efficacy of Avatrombopag in Thrombocytopenic Patients With Chronic Liver Disease Undergoing an Elective Procedure [Phase 4]

View source ↗

Summary

Phase 4 clinical trial evaluating avatrombopag for thrombocytopenia in patients with chronic liver disease undergoing an elective procedure.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Liver Disease
• Thrombocytopenia

Drugs mentioned

• Avatrombopag (avatrombopag)

Snippet

Sponsor: Chinese PLA General Hospital | Conditions: Thrombocytopenia; Drugs, Chronic Liver Disease | Phase 4 | Status: UNKNOWN